To determine whether acute silencing of Atmin in tumor cells might reduce Pdgfra expression by disrupting Atm signaling, we tested the effects of pharmacological Atm inhibition in p53ΔNprimary tumor cells. This evidence concerns the gene PDGFRA and neoplasm.